ResearcherNorth Sichuan Medical UniversityActive in the last 2 years
Gang Quan
Matched on ORCID iD 0000-0001-9234-7527; OpenAlex author ID A5010959633. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 15
2022: 2 papers · 2023: 2 papers · 2024: none · 2025: none · 2026: 2 papers
Papers 6
- Investigation of a GPC1-targeted and LIFU-responsive nanoplatform with ADV effect for visualized chemo-sonodynamic therapy against pancreatic ductal adenocarci… First author DOI 10.1007/s00432-026-06518-5↗
- A GPC1-Targeting multifunctional nanoplatform combining paclitaxel-mediated chemotherapy and chlorin e6-assisted sonodynamic therapy for Pancreatic Ductal Aden… Co-author DOI 10.1016/j.ctarc.2026.101139↗
- KIF15 is essential for USP10-mediated PGK1 deubiquitination during the glycolysis of pancreatic cancer. Co-author DOI 10.1038/s41419-023-05679-2↗
- VSIG2 promotes malignant progression of pancreatic ductal adenocarcinoma by enhancing LAMTOR2-mediated mTOR activation. First author DOI 10.1186/s12964-023-01209-x↗
- LINC00941 promotes pancreatic cancer malignancy by interacting with ANXA2 and suppressing NEDD4L-mediated degradation of ANXA2. Co-author DOI 10.1038/s41419-022-05172-2↗
- Hypoxia-Induced miR-210 Promotes Endothelial Cell Permeability and Angiogenesis via Exosomes in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1155/2022/7752277↗
Closest collaborators
The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Jianxin Jiang · 3 shared papers, 2022–2023 · strength 0.66
- Paper VSIG2 promotes malignant progression of pancreatic ductal adenocarcinoma by enhancing LAMTOR2-mediated mTOR activation. DOI 10.1186/s12964-023-01209-x↗
- Paper KIF15 is essential for USP10-mediated PGK1 deubiquitination during the glycolysis of pancreatic cancer. DOI 10.1038/s41419-023-05679-2↗
- Paper LINC00941 promotes pancreatic cancer malignancy by interacting with ANXA2 and suppressing NEDD4L-mediated degradation o… DOI 10.1038/s41419-022-05172-2↗
- Bo Ren · 2 shared papers, 2026 · strength 0.58
- Paper Investigation of a GPC1-targeted and LIFU-responsive nanoplatform with ADV effect for visualized chemo-sonodynamic ther… DOI 10.1007/s00432-026-06518-5↗
- Paper A GPC1-Targeting multifunctional nanoplatform combining paclitaxel-mediated chemotherapy and chlorin e6-assisted sonody… DOI 10.1016/j.ctarc.2026.101139↗
- Jichuan Xu · 2 shared papers, 2023 · strength 0.48
- Xinyuan Liu · 2 shared papers, 2022–2023 · strength 0.39
- Paper KIF15 is essential for USP10-mediated PGK1 deubiquitination during the glycolysis of pancreatic cancer. DOI 10.1038/s41419-023-05679-2↗
- Paper LINC00941 promotes pancreatic cancer malignancy by interacting with ANXA2 and suppressing NEDD4L-mediated degradation o… DOI 10.1038/s41419-022-05172-2↗
- Charng Choon Wong · 1 shared paper, 2026 · strength 0.30
- Jingdong Li · 1 shared paper, 2026 · strength 0.30
- Wong Charng Choon · 1 shared paper, 2026 · strength 0.28
- Jie Wang · 1 shared paper, 2023 · strength 0.22
- Yaqin Wang · 1 shared paper, 2022 · strength 0.17
- Zhiwei He · 1 shared paper, 2022 · strength 0.17
- Xueyi Jiang · 1 shared paper, 2022 · strength 0.17
- Jie Wang · 1 shared paper, 2022 · strength 0.17
- Jian Xu · 1 shared paper, 2022 · strength 0.17
- Guo Wu · 1 shared paper, 2022 · strength 0.17
- Zhonghu Li · 1 shared paper, 2022 · strength 0.17
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.